Analyses of safety, extent of exposure, PK, efficacy, and immunogenicity will be based on all treated participants. 10.3 Statistical Analyses The statist ical analy sis plan will be developed and finalized before database lock. Below is a summary of planned statist ical analyses of the pr imary and secondary e ndpoints. In general, summaries will be performed by c ohort.